Form 8-K - Current report:
SEC Accession No. 0001104659-24-116782
Filing Date
2024-11-12
Accepted
2024-11-12 16:13:04
Documents
15
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2428070d1_8k.htm   iXBRL 8-K 25928
2 EXHIBIT 99.1 tm2428070d1_ex99-1.htm EX-99.1 89288
6 GRAPHIC tm2428070d1_ex99-1img01.jpg GRAPHIC 6498
  Complete submission text file 0001104659-24-116782.txt   308871

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA eyen-20241112.xsd EX-101.SCH 3015
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE eyen-20241112_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eyen-20241112_pre.xml EX-101.PRE 22359
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2428070d1_8k_htm.xml XML 3676
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38365 | Film No.: 241448285
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)